General Updates

Nectar Lifesciences Ltd. Ref. No.: NLL/CS/2026- WFH August 15, 2026 1. National Stock Exchange of India Limited 2. BSE Limited Listing Department, Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, P J Towers, Dalal Street, Bandra (E), Mumbai 400 051 Mumbai 400 001 Symbol: NECLIFE Scrip Code: 532649 Ref.: Regulation 30 of Securities and Exchange Board of India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulation”). Dear Sir/ Madam, We wish to inform you that the board of directors of Nectar Lifesciences Limited (“Company”) in their meeting held on August 14, 2026, have, inter-alia, noted, decided and approved the change in corporate office of the Company from Plot No. 110, Industrial Area, Phase 1, Chandigarh 160 002 to "Godrej Eternia," West Wing (Tower A), Plot No. 70, Industrial Area, Phase-1, Chandigarh, 160 002. with effect from September 15, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Nectar Lifesciences Limited (Sanjaymohan Singh Rawat) Company Secretary & Compliance Officer Corporate Office: Plot No. 110, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664